NeurOP's Angel - III Round

NeurOP raised a round of funding on December 23, 2011. Investors include Ariel Savannah Angel Partners.

NeurOp is a biopharmaceutical company developing new medicines to treat central nervous system disorders, including major depression, neuropathic pain and ischemia. The company's mission is to develop…

Articles about NeurOP's Angel - III Round: